industri cross current pick sinc provid
guidanc combo deceler gener purchas benefit
lower brand inflat vertic deal close could make
difficult management deliv ep w/in con rang wbad cost
save share buyback key swing factor pt
meet manag last week see went back re-
evalu model assumpt implic chang inflat
supplier/payor relationship walgreen bottom line lead us updat
key factor model higher pharmaci reimburs pressur
million million headwind lower brand inflat bp tailwind
bp tailwind growth vs bp tailwind last year
acceler share shift newli vertic integr marketplac bp
headwind growth result lower ebit
billion billion ebit bridg exhibit
new ep consensu whether
manag execut buy-back plan key swing factor
potenti sourc upsid estim ep bridg see exhibit
suggest ep rang could low accordingli
lower ep forecast vs prior three key
swing factor analysi includ reimburs pressur assum
bp associ gross margin pressur base manag comment
see higher reimburs pressur rel given lack
offset subsidi busi wbad cost save gener
manufactur scale back channel discount larg purchas group
includ walgreen wbad quantifi impact step gener
deflat high-single-digit mid-single-digit bp headwind
walgreen ebit growth compar last year buy back
guidanc call billion share buyback question whether given
chang macro environ step reimburs pressur
manag would consid buyback best use capit model
 distribut unit state america
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
assum billion worth repurchas headwind
price target price target deriv use multiples-
multipl lower adjust ebitda estim billion
billion previous base case target repres upsid last close
price bull case price target goe bear case
price target goe note base case appli multipl
chang rel prior price target price target chang
entir due lower ebitda assumpt
deriv base case scenario assign ev/ebitda
multipl adj ebitda
ev/ebitda multipl appli adjust ebitda
ev/ebitda multipl appli adjust ebitda
ebitda assum script growth front store comp
synergi bp pharmaci reimburs pressur fulli off-set
exclud histor peak multipl view unlik absent
accret strateg acquisit and/or subsid amazon threat well
exclud trough multipl use six year averag multipl
exclud period multipl compress due
combin compani specif issu disput express script
ev/ebitda multipl adj ebitda
ev/ebitda multipl adj ebitda
ebitda assum script growth flat front store comp
synergi bp pharmaci reimburs pressur partial
off-set wbad cost save assign multipl reflect year average
multipl exclud peak multipl view unlik
absent accret strateg acquisit and/or subsid amazon
ev/ebitda multipl appli adjust ebitda
ev/ebitda multipl appli adjust ebitda
ebitda ssume script growth front store comp synergi
wbad cost save off-set pharmaci reimburs pressur
assign multipl repres trough multipl amazon/pillpack
acquisit announc
retail pharmaci chain us well
boot pharmaci allianc drug
distribut europ
expect benefit
eas year-over-year comparison lap
part contract loss contribut
fred anoth round cost
reduct underli fundament still
walgreen balanc sheet deploy
capit well strateg
option eg lh potenti
reposit portfolio asset chang
strategi provid roadmap futur
growth potenti catalyst share
updat rad/fr integr
sg leverag fail materi
risk achiev price
walgreen abl drive market
store integr drive higher
expect save
exhibit walgreen ebit bridg
morgan stanley estim compani data
exhibit walgreen ep bridg
morgan stanley estim compani data
valuat methodolog risk
ew price target deriv assign ev/ebitda multipl
adj ebitda assign multipl reflect year average multipl exclud
peak multipl view unlik absent accret strateg acquisit
and/or subsid amazon threat exclud trough multipl
risk target includ market script growth store integr
drive higher expect potenti increas cost save
inform opinion research prepar co llc and/or and/or morgan
stanley mexico de bolsa de and/or canada limit use disclosur section includ morgan
stanley co llc mexico de bolsa de canada limit affili
necessari
import disclosur stock price chart equiti rate histori regard compani subject report pleas see morgan
stanley research disclosur websit www morganstanley com/researchdisclosur contact invest repres
research broadway attent research manag new york ny usa
valuat methodolog risk associ recommend rate price target referenc research report pleas contact client
support follow us/canada hong kong latin america london
singapor sydney tokyo altern may contact invest repres morgan
stanley research broadway attent research manag new york ny usa
follow analyst herebi certifi view compani secur discuss report accur express
receiv receiv direct indirect compens exchang express specif recommend view report ricki
unless otherwis state individu list cover page report research analyst
morgan stanley research publish accord conflict manag polici avail
www morganstanley com/institutional/research/conflictpolici portugues version polici found www morganstanley com br
import us regulatori disclosur subject compani
